Grand Rounds, July 10, 2025


July 10, 2025

Presentation Title: Under the Bell Jar: A Historical Perspective on Pulmonary Function Tests

Speaker: Gautam Sikka, MD


Date: Thursday, July 10, 2025
Time: 12:00 PM – 1:00 PM
Location: MSB 2.103
Learning Format: In-Person and Online


Series Objectives:

  • Apply the latest evidence with patients and practice evidence-based medicine.
  • Discuss current research and its potential for application to patient care.
  • Discuss the latest clinical practice guidelines relevant to clinical practice.

Learning Objectives:
At the conclusion of this activity, participants should be able to:

  • Describe the major historical milestones in the evolution of pulmonary function testing from antiquity to the modern era.
  • Identify the key contributors and inventions that have shaped the field of respiratory physiology.
  • Differentiate between historical and contemporary PFT techniques and understand how advances in technology have improved diagnostic accuracy and clinical utilization.

Accreditation Statement:

  • McGovern Medical School at the University of Texas Health Science Center at Houston is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation:

  • McGovern Medical School at the University of Texas Health Science Center at Houston designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • McGovern Medical School at the University of Texas Health Science Center at Houston designates this live activity for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.

 

Event Disclosures:
Speakers:
Gautam Sikka, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

  • Clavrivate – One time Q&A on future of Sarcoidosis – Relationship Ended

Any financial relationship that was found to be relevant has been mitigated.


Planners and other Administrative Support:
Tanvi Gupta, MD, Gabriel Aisenberg, MD, Philip Orlander, MD, Jeffrey Chen, MD, Mark A Farnie, MD, Robby Wesley, DO, FACP, Charani Kamath Shenoy, MD, and Andrew Sullivan, MD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.


Commercial Support:
This activity is not commercially supported.


UTHealth Internal Medicine Grand Rounds
The Walter M. Kirkendall, MD and Margaret A. Kirkendall Annual Endowed Lecture Series



Related topics